From that Jacob Rowe research note
"This is what the valuation is today, and in three years it could be a much much higher valuation depending on how the team executes on both QLE and ASPI we could see valuations go well above $8b with each entity having possibly valuations of $3b+ (QLE) and $5b+ (ASPI)."
So this guy is talking US8b valuation v US500m today before the Renergen deal is added to ASPI ?
Renergen alone at US300m ebitda per year with a x 20 multiple could be worth US6b by itself also I guess. Or higher longer term if ebitda outperforms to US500m + for instance.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.08 |
Change
-0.040(3.57%) |
Mkt cap ! $32.75M | |||
| Open | High | Low | Value | Volume |
| $1.06 | $1.09 | $1.05 | $23.15K | 21.70K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4726 | $1.05 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.09 | 2214 | 1 |
View Market Depth
| Last trade - 15.57pm 13/06/2025 (20 minute delay) ? |
| RLT (ASX) Chart |